Pelthos Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Pelthos Therapeutics Inc. (PTHS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.510.100.060.000.00
Cash & Short-Term Investments0.510.100.060.000.00
Accounts Receivable0.040.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.820.000.000.000.00
Total Current Assets1.370.100.060.000.07
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.000.000.000.000.00
Total Assets1.370.100.060.000.07
Current Liabilities
Accounts Payable1.904.622.992.583.41
Short-Term Debt2.191.270.540.000.00
Accrued Liabilities0.000.650.220.000.00
Other Current Liabilities0.000.010.010.000.00
Total Current Liabilities4.086.543.762.583.65
Non-Current Liabilities
Long-Term Debt0.000.000.001.100.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.000.000.000.000.00
Total Liabilities4.086.543.763.683.65
Stockholders' Equity
Common Stock0.000.000.000.00-3.58
Retained Earnings-21.47-13.52-6.14-3.680.00
Additional Paid-in Capital18.767.072.430.000.00
Shares Outstanding0.610.580.580.000.00
Total Stockholders' Equity-2.71-6.44-3.71-3.68-3.58
Total Liabilities & Equity1.370.100.060.000.00